Aditxt (ADTX) Cash from Financing Activities (2019 - 2026)

Aditxt (ADTX) recorded quarterly Cash from Financing Activities of $1.7 million in Q1 2026, down 86.5% quarter-over-quarter from $12.3 million in Q4 2025, and down 85.39% on a YoY basis from $11.4 million in Q1 2025.

Aditxt (ADTX) Cash from Financing Activities (2019 - 2026) Analysis & Trends

Aditxt's Cash from Financing Activities history runs 8 years deep, the most recent figure standing at $1.7 million for Q1 2026.

  • In Q1 2026, Cash from Financing Activities fell 85.39% year-over-year to $1.7 million; the TTM figure through Mar 2026 stood at $20.8 million (down 25.47% YoY), while the FY2025 annual figure was $30.5 million, up 35.53% from the prior year.
  • Cash from Financing Activities was $1.7 million for Q1 2026 at Aditxt, down from $12.3 million in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $16.2 million in Q3 2022 to a low of -$184184.0 in Q1 2022.
  • Historically, Cash from Financing Activities has averaged $5.2 million across 5 years, with a median of $3.3 million in 2024.
  • The sharpest annual moves came in 2022 and 2023: Cash from Financing Activities plunged 102.28% in 2022, then jumped 3620.97% in 2023.
  • A 5-year view of Cash from Financing Activities shows it stood at $64012.0 in 2022, then surged by 3620.97% to $2.4 million in 2023, then surged by 294.29% to $9.4 million in 2024, then surged by 30.92% to $12.3 million in 2025, then sank by 86.5% to $1.7 million in 2026.
  • The last three Cash from Financing Activities figures came in at $1.7 million (Q1 2026), $12.3 million (Q4 2025), and $2.2 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 7.00 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -600,000.00
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 53,000.00
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn -538.80 Mn
9 Abivax 91.96 Bn 91.96 Bn - 85,464.43
10 Aditxt 2,485.68 -2.16 Mn 2,868.00 1.66 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 1.66 Mn
Mar 31, 2026 1.66 Mn
Dec 31, 2025 12.29 Mn
Dec 31, 2025 12.29 Mn
Sep 30, 2025 2.18 Mn
Sep 30, 2025 2.18 Mn
Jun 30, 2025 4.66 Mn
Jun 30, 2025 4.66 Mn
Mar 31, 2025 11.36 Mn
Mar 31, 2025 11.36 Mn
Dec 31, 2024 9.39 Mn
Dec 31, 2024 9.39 Mn
Sep 30, 2024 3.86 Mn
Sep 30, 2024 3.86 Mn
Jun 30, 2024 3.29 Mn
Jun 30, 2024 3.29 Mn
Mar 31, 2024 5.95 Mn
Mar 31, 2024 5.95 Mn
Dec 31, 2023 2.38 Mn
Dec 31, 2023 2.38 Mn